Portugal, April 27 -- Portugal based Quilaban, S.A has secured contract from Instituto Portugues De Oncologia De Lisboa Fg, E.P.E. for Nextseq 1000 2000 P1 Reagent 600Cycles. The value of the contract is worth 2039796 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....